This text is a result of machine translation.
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Shanghai Petrochemical: it will cooperate with the investigation that the shutdown of relevant devices will not have a significant impact on the market
Shanghai Petrochemical: the fire has been controlled
The total box office of Jurassic world 3 exceeded 300million
Weibo Experienced a Surge in Advertising Revenue Worth USD 427 Mn in Q1 2022
On June 1, China’s leading social media platform Weibo released its annual financial statements for the first quarter of 2022. The company’s advertising revenue reached USD 427 million, up 10% year on year.
Jun 03, 2022 12:59 AM
Hong Kong IPO at a Glance: Weibo Corporation
The Twitter-like platform completed its secondary listing on December 8, 2021.
Dec 08, 2021 10:03 PM
Issuance of guidelines on remuneration management of fund companies bound to the interests of holders
Guangdong 711 responded to the inappropriate advertising language of the poster: the relevant stores have been ordered to remove the poster immediately
Most of the popular Chinese stocks rose before the US market, and the B station rose by more than 7%
China Advertising Association issued a document on the suspected plagiarism of Audi brand advertising
New urbanization stocks fell in shock
Black Friday Kicks Off: How to Navigate the Latin American Market?
Nov 20, 2024 10:36 AM
Exploring Uncharted Territories in the Middle East: The Innovators Going Global
Nov 19, 2024 03:20 PM
The Billion-Dollar European Caviar Business, Now Disrupted by China
Nov 08, 2024 01:52 PM